RxDoctor Payments Data

Ashley McFerron

Optometrist · Canby, ORNPI 1073776829

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,700 of the $3,526 with a category attached, or 76.6%. Coopervision Inc. accounts for 60.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $1,804 and has fallen 77.8% since, to $400 in 2025. Among optometrist clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,526in general payments, 2019–2025

Across 55 payments — averaging $64.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$2K
  • Alcon$706
  • Maculogix, Inc.$250
  • Genentech USA, Inc.$109
  • Johnson & Johnson Vision Care, Inc.$81
  • Bausch & Lomb Americas Inc.$72
  • plus $185 from 6 others

What the payments were for

  • Consulting fees$201%
  • Speaking & faculty fees$1524%
  • Travel & lodging$59917%
  • Food & beverage$2,70077%
  • Gifts$70%
  • Entertainment$491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,526 in reported general payments places this provider in the 90th percentile of 684 optometrist providers in Oregon.

See all optometrist providers in Oregon

Medicare billing

Part B allowed, 2024
$23,157
Medicare patients
115
Services billed
240

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol21$1,970
BetimolTimolol12$1,902
Latanoprost101$1,367
Timolol Maleate38$352
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha22$259

Paid to pharmacies, not to this prescriber.

Other optometrist in Canby

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →